Other Information
−Removed: On October 24, 2025, Dr.
−Removed: Maryland, a valued member of the Company’s Board of Directors since February 2021, passed away at the age of 72.
−Removed: Maryland was a deeply respected and admired leader, offering thoughtful counsel and demonstrating an unwavering commitment to advancing access, equity and excellence in healthcare.
−Removed: The Company’s Board of Directors and management team extend their deepest condolences to Dr.
−Removed: Maryland’s family and express profound gratitude for the positive impact she had on the Company and communities we serve.
−Removed: Maryland was a member of the Nominating and Corporate Governance and Compliance and Ethics Committees.
−Removed: In connection with these events, Dr.
−Removed: Laura Forese was appointed by the Board as a member of the Nominating and Corporate Governance Committee.
−Removed: The Board will review the composition of its committees and overall membership in due course and will take appropriate action in accordance with the Company’s bylaws.
Insider Trading Arrangements
From time to time, certain of our executive officers and directors have, and we expect they will in the future, enter into, amend and terminate written trading arrangements pursuant to Rule 10b5-1 of the Securities and Exchange Act of 1934 or otherwise.
−Removed: During the three months ended September 30, 2025, none of the Company’s directors or officers adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).
−Removed: 10 Second Amendment to Credit Agreement, dated as of August 13, 2025, by and among SP Holdco I, Inc., Surgery Center Holdings, Inc., the Subsidiary Guarantors, Jefferies Finance LLC, and the other lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed August 13, 2025).
+Added: During the three months ended March 31, 2026, none of the Company’s directors or officers adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).
31.1 Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
8 unchanged sentences
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: 104 The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline XBRL (included in Exhibit 101).
+Added: 104 The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in Inline XBRL (included in Exhibit 101).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SURGERY PARTNERS, INC.
−Removed: November 10, 2025 By:
+Added: May 5, 2026 By:
Executive Vice President and Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.